Pharmacotherapy for attention-deficit/hyperactivity disorder
نویسندگان
چکیده
منابع مشابه
Pharmacotherapy of attention-deficit hyperactivity disorder.
Attention-deficit hyperactivity disorder, characterized by poor sustained attention, diminished impulse control and excessive physical activity, is found in most cultures and most countries. However, diagnostic terminology and management vary from centre to centre. Pharmacotherapy in conjunction with individual and family therapy is generally accepted as the most effective treatment, while psyc...
متن کاملAttention-deficit/hyperactivity disorder: etiology and pharmacotherapy.
Attention-deficit/hyperactivity disorder is a common neurobehavioral disorder of childhood and adolescence. The etiology of attention-deficit/hyperactivity disorder is not well understood. Neurochemical studies suggest, alterations in catecholaminergic, mainly dopaminergic and noradrenergic, transmitter functions markedly contribute to the symptoms of this disorder. The symptoms of attention-de...
متن کاملPharmacotherapy of adult attention deficit/hyperactivity disorder: a review.
Adult attention deficit/hyperactivity disorder (ADHD) is an increasingly recognized disorder with associated psychiatric comorbidity and impairment. Although pharmacotherapy serves an important role in treating ADHD and other concurrent psychiatric disorders in children and adolescents, the use of pharmacotherapeutics for adults with ADHD remains less established. In this report, the effectiven...
متن کاملCombined methylphenidate and atomoxetine pharmacotherapy in attention deficit hyperactivity disorder.
OBJECTIVES Pharmacological treatment of attention deficit hyperactivity disorder (ADHD) includes stimulant and non-stimulant medications. Our purpose in this study is to investigate efficacy, safety and tolerability of combined methylphenidate and atomoxetine pharmacotherapy. METHODS We included 12 patients of the 824 patients with ADHD using methylphenidate and atomoxetine combined therapy b...
متن کاملAttention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy.
Throughout this decade, there has been significant research into pharmacotherapies for attention-deficit hyperactivity disorder (ADHD). This article considers the efficacy and safety of five of the more novel long-acting pharmacological treatments recently approved by the FDA for marketing in the US for paediatric ADHD, along with an alpha(2)-adrenoceptor agonist in preparation. Reviewed treatm...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Korean Medical Association
سال: 2019
ISSN: 1975-8456,2093-5951
DOI: 10.5124/jkma.2019.62.1.49